Montgomery Åsberg Depression Rating Scale

Abstract

The Montgomery Åsberg Depression Rating Scale (MADRS) is a highly validated, 10-item psychometric instrument designed primarily to assess the severity of depressive symptoms and monitor changes in patients undergoing treatment. The items comprising the MADRS were carefully selected from the broader 65-item Comprehensive Psychopathology Rating Scale (CPRS) based on their prevalence and sensitivity to change in depressive states. The scale employs a unique 7-point scoring system that utilizes predefined anchor points at two-point intervals (0, 2, 4, 6), requiring the assessor to determine whether the patient’s condition falls on or between these specific steps (1, 3, 5). The MADRS can be administered either as a structured clinician interview or in a self-report format.

Keywords

Depression, MADRS, Rating Scale, Psychopathology, Affective Disorder, Clinical Assessment, Symptom Severity, Treatment Monitoring.

Authors

Montgomery SA, Åsberg M (1979), Hartong EGTM, Goekoop JG (1985) (for the Dutch adaptation).

[quads id=5]

Purpose

The primary purpose of the MADRS is to quantify the severity of a major depressive episode and, crucially, to track changes in symptom intensity over time, particularly in response to pharmacological or psychological interventions. It is widely utilized in clinical trials due to its known sensitivity to treatment effects, making it a superior tool for measuring progress compared to scales designed primarily for initial diagnostic screening.

While the scale provides a robust measure of depression severity, it is not intended as a stand-alone diagnostic tool but rather as a standardized method for assessing the core manifestations of the disorder. Its concise 10-item structure ensures efficient administration while maintaining high clinical relevance.

Construct

The MADRS measures the core psychological construct of clinical depression severity, focusing on the affective, cognitive, and somatic dimensions of the disorder. The 10 items assess specific symptoms that are highly characteristic of depression and are known to respond differentially to treatment. These domains include apparent sadness, inner tension, reduced sleep, reduced appetite, difficulty concentrating, lassitude, inability to feel, pessimistic thoughts, and suicidal thoughts.

The selection of these items from the original 65-item Comprehensive Psychopathology Rating Scale (CPRS) was deliberate, focusing on symptoms that reflect the depth of the depressive state rather than general psychiatric distress. This focused approach allows the scale to effectively gauge the severity of the illness and its impact on daily functioning.

Validity

The MADRS demonstrates strong evidence of **concurrent validity**, showing high correlations with other widely accepted measures of depression severity, such as the Hamilton Rating Scale for Depression (HAM-D), often exceeding 0.90. This indicates that the MADRS measures the same underlying construct as other established instruments.

Furthermore, the scale exhibits robust **discriminant validity**, reliably differentiating between individuals diagnosed with major depressive disorder and those suffering from other psychological disorders or healthy control groups. Its focused content, derived from the CPRS, ensures high **content validity**, covering the essential symptom domains necessary for comprehensive clinical assessment of depression.

Reliability

The internal consistency of the MADRS is consistently reported as excellent, with Cronbach’s alpha coefficients typically ranging from 0.85 to 0.92 across various clinical populations. This high level of internal consistency confirms that the 10 items are homogeneous and measure a unified construct of depressive severity.

Crucially, the MADRS also possesses strong **inter-rater reliability**, especially when administered by trained clinicians adhering to standardized scoring procedures. This reliability is vital, given that the scoring relies on nuanced clinical judgment to place the patient’s state accurately onto the 7-point rating scale, which includes intermediate steps (1, 3, 5) between defined anchor points (0, 2, 4, 6).

Factor Analysis

Factor analytical studies of the MADRS often support a highly cohesive structure, frequently confirming a dominant, robust single factor representing overall depressive severity. This single-factor model is the basis for using the total score as the primary clinical outcome measure.

However, depending on the population and statistical methodology used, some research suggests the presence of two or three sub-factors. These commonly identified sub-factors include an ‘Affective/Cognitive’ dimension (covering items like sadness, pessimism, and concentration difficulties) and a ‘Somatic’ dimension (including reduced sleep, appetite, and lassitude). Regardless of minor variations in factor structure, the MADRS total score remains the definitive metric for assessing treatment response in depression.

Instrument

Test Type: Questionnaire / Clinical Rating Scale

Format: The scale consists of 10 items, each rated on a 7-point rating scale ranging from 0 (absent) to 6 (severe). Scoring uses two-point interval anchor definitions (0, 2, 4, 6), requiring the assessor to utilize intermediate scores (1, 3, 5) if the severity falls between the defined steps. The maximum score is 60.

Language Available: English (original), Dutch (Hartong EGTM, Goekoop JG, 1985), and numerous other languages globally.

Population Group: Adults, Elderly

Age Group: Typically 18 years and older.

Population Details: Individuals suspected of or diagnosed with major depressive disorder or other affective disorders, particularly those enrolled in treatment efficacy studies.

Test Methodology: The scale is typically administered by a trained clinician during a structured or semi-structured interview, where the rating is based on both the patient’s self-report and the clinician’s observation of the patient’s behavior and demeanor. Self-report versions are also available.

Keywords

Affective disorders, Symptom severity, Clinical assessment, Psychometrics, Treatment monitoring, Clinical trials.

[quads id=5]

Authors

Author ORCID Identifier: N/A (Information not provided in source)

Affiliation Email addresses: N/A (Information not provided in source)

Correspondence Address: N/A (Information not provided in source)

Permissions & Fee and Test Year

The original Montgomery Åsberg Depression Rating Scale was first published in **1979**. The Dutch adaptation was published in **1985**. While the scale is widely used in academic research, specific permissions and licensing fees for commercial or clinical applications should be sought directly from the original copyright holders or subsequent licensed distributors.

Reference’s

• Montgomery SA, Åsberg M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389.
• Hartong EGTM, Goekoop JG. (1985). De Nederlandse versie van de Montgomery Åsberg Depression Rating Scale (MADRS). [Dutch adaptation].

[quads id=5]

Items of the Montgomery Åsberg Depression Rating Scale

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

The 10 items of the MADRS cover the following domains (original item descriptions were not provided in the source text, but the full instrument documentation is available via the links below).

The original explanatory form (Toelichtingsformulier) can be downloaded here: MADRS Explanation Form PDF.

The original measurement instrument (Meetinstrument) can be downloaded here: MADRS Measurement Instrument PDF.